Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Bak

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Molecular Therapy. Methods & Clinical Development|August 8, 2025
Development of cell-based assay for detecting replication-competent adeno-associated virus by qPCRAishwarya Shevade, John S Reeves, Hanne Bak, et al.
Mabs|March 11, 2016
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidityAndrew D Tustian, Christine Endicott, Benjamin Adams, et al.
Molecular Therapy. Methods & Clinical Development|April 11, 2025
A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectorsGarima Thakur, Sheldon Mink, Ana J Garcia, et al.
Biotechnology Progress|February 22, 2018
Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidityAndrew D Tustian, Linus Laurin, Henrik Ihre, et al.
Expert Review of Anti-Infective Therapy|January 11, 2019
Cross-programmatic consultation on the role of primary care in the responsible use of medicines and the reduction of antimicrobial resistanceKotoji Iwamoto, Hanne Bak Pedersen, Juan E Tello, et al.
Mabs|August 4, 2020
A general evidence-based sequence variant control limit for recombinant therapeutic protein developmentAming Zhang, Zhengwei Chen, Meinuo Li, et al.
Biotechnology and Bioengineering|June 4, 2025
Scalable Production of Recombinant Vesicular Stomatitis Virus Pseudoparticles Using HEK293 Suspension CulturesZhe Zhang, Elzbieta Wloga, Benjamin O Fulton, et al.
Vaccine|December 16, 2023
The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemicTania Cernuschi, Stefano Malvolti, Shanelle Hall, et al.
Pharmaceutical Research|January 4, 2022
Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipasesSisi Zhang, Caterina Riccardi, Douglas Kamen, et al.
Biotechnology Progress|March 7, 2024
High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditionsLouis Coplan, Zhe Zhang, Nicole Ragone, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|August 8, 2025
Development of cell-based assay for detecting replication-competent adeno-associated virus by qPCRAishwarya Shevade, John S Reeves, Hanne Bak, et al.
Mabs|March 11, 2016
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidityAndrew D Tustian, Christine Endicott, Benjamin Adams, et al.
Molecular Therapy. Methods & Clinical Development|April 11, 2025
A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectorsGarima Thakur, Sheldon Mink, Ana J Garcia, et al.
Biotechnology Progress|February 22, 2018
Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidityAndrew D Tustian, Linus Laurin, Henrik Ihre, et al.
Expert Review of Anti-Infective Therapy|January 11, 2019
Cross-programmatic consultation on the role of primary care in the responsible use of medicines and the reduction of antimicrobial resistanceKotoji Iwamoto, Hanne Bak Pedersen, Juan E Tello, et al.
Mabs|August 4, 2020
A general evidence-based sequence variant control limit for recombinant therapeutic protein developmentAming Zhang, Zhengwei Chen, Meinuo Li, et al.
Biotechnology and Bioengineering|June 4, 2025
Scalable Production of Recombinant Vesicular Stomatitis Virus Pseudoparticles Using HEK293 Suspension CulturesZhe Zhang, Elzbieta Wloga, Benjamin O Fulton, et al.
Vaccine|December 16, 2023
The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemicTania Cernuschi, Stefano Malvolti, Shanelle Hall, et al.
Pharmaceutical Research|January 4, 2022
Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipasesSisi Zhang, Caterina Riccardi, Douglas Kamen, et al.
Biotechnology Progress|March 7, 2024
High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditionsLouis Coplan, Zhe Zhang, Nicole Ragone, et al.
Pageof 4